Controversies in the Treatment of Peripheral T-cell Lymphoma-Reference-Cited by-同舟云学术

Controversies in the Treatment of Peripheral T-cell Lymphoma

Published:2020-09-01 Issue:5 Volume:4 Page:e461
ISSN:2572-9241
Container-title:HemaSphere
language:en
Short-container-title:

Author:

Bachy Emmanuel,Broccoli Alessandro,Dearden Claire,de Leval Laurence,Gaulard Philippe,Koch Raphael,Morschhauser Franck,Trümper Lorenz,Zinzani Pier Luigi

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hematology

Reference108 articles.

1. New insights in the pathogenesis of T-cell lymphomas;Lemonnier;Curr Opin Oncol.,2018

2. Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters;Lemonnier;Blood.,2012

3. TET2 and DNMT3A mutations in human T-cell lymphoma;Couronne;N Engl J Med.,2012

4. Type II Enteropathy-Associated T-Cell Lymphoma Features a Unique Genomic Profile with Highly Recurrent SETD2 Alterations;Roberti;Nat Commun.,2016

5. The genetic basis of hepatosplenic T-cell lymphoma;McKinney;Cancer Discov.,2017

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autologous Stem Cell Transplant in Hodgkin’s and Non-Hodgkin’s Lymphoma, Multiple Myeloma, and AL Amyloidosis;Cells;2023-12-18

2. Real-world treatment patterns, healthcare resource utilization and costs among patients with peripheral T-cell lymphoma;Future Oncology;2023-10-10

3. Computational discovery of binding mode of anti-TRBC1 antibody and predicted key amino acids of TRBC1;Scientific Reports;2022-02-02

4. Role of lenalidomide in the treatment of peripheral T-cell non-Hodgkin lymphomas;World Journal of Clinical Oncology;2021-10-24

5. An indolent nasal form of primary cutaneous CD8‐positive peripheral T‐cell lymphoma not otherwise specified successfully treated with local radiation therapy: A new subtype?;Dermatologic Therapy;2021-02-23